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ABSTRACT 
32-microgl°bulin (32a) has been purified over 1500- 
fold from the serum of miniature swine poisoned with sodium 
chromate. Relative to the amount of activity in the 
original serum sample, a 52.2% yield was obtained. A hetero- 
125 
logous radioimmunoassay (RIA) inhibition test (using I-human 
$2y and goat-anti-rabbit (GAR) $2a) was used to detect 
fractions containing swine 32a activity in each step of the 
purification procedure. A procedure of gel chromatography with 
Sephadex G-75 followed by ion exchange chromatography with DEAE- 
cellulose was used in the purification. Additional attempts 
to purify the £2a by isoelectric focusing and ion exchange 
chromatography with CM-cellulose were not successful. Preliminary 
SDS polyacrylamide gels revealed an 11,000 Dalton putative 62a 
peak free of most contaminants. This 62a has been used to immunize 
a goat, and initial Ouchterlony immunodiffusion tests have shown 
the ability of the goat-anti-swine 62a to form precipitin lines 
with the purified swine 62a- 

INTRODUCTIC 
g 2-microglobulin (g2y) is a small protein produced by 
many cell types, including lymphocytes and cells of epithelial 
and mesenchymal origin (10,40,47). After synthesis within the 
cell, it can either be transported to the cell surface, or it 
can be secreted and is thus found to a snail extent in normal 
body fluids (41). The protein was named on the basis of its 
snail size and its B globulin electrophoretic mobility (49). 
First isolated from human urine (8), homologues of 32a have now 
been isolated and purified from many species, including guinea 
pig (16), rabbit (6,20,21), mouse (2,39,53), dog (57), cow (31), 
rat (48), and chicken (66). These homologues of B21-J share many 
structural characteristics. They are all simple polypeptides of 
about 100 amino acids, containing no carbohydrate, and have 
molecular weights between 11,000 and 13,000 Daltons. All except 
the cow B2V1 homologue are monomeric, with one intrachain disulfide 
bond forming a loop involving 57 amino acids. 
The kidney is responsible for much of the catabolism of ggiu 
Like many small proteins, 32U is filtered through the glomerulus 
and is reabsorbed and catabolyzed by proximal tubular cells (8,26). 
Under normal circumstances, only small amounts of 3 2u can be 
measured in serum and urine, but in cases of renal failure and 
tubular damage, the serum and urinary levels of 3 2'J may increase 
more than a thousandfold (44). Increased serum levels are also 
seen in lymphoproliferative disorders (9). These cases provide a 
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source from which Bov* may be isolated. 
The study of B^p has become an area of great interest to 
imnunologists because of the resemblance of BoP ho subunits of 
immunoglobulins and because it has been found to be a subunit of 
histocompatibility antigens. The structural similarities among 
these molecules may imply that they share a similar function, as 
well as a common evolutionary origin. Therefore it is important 
to study B2P as a model which may clarify the functions of and 
interrelationships among certain other important cell surface 
proteins. 
Relationship with Immunoglobulins. One of the first 
observations about B2P was that its structure resembled that of 
the constant regions of an inmunoglobulin G (IgG) domain (19,20,22). 
Both contain about the same number of amino acids and have one 
intrachain disulfide bond. Each has a compact globular structure 
with seme B-pleated sheet regions. Most importantly, there is 
considerable amino acid homology between the two, particularly 
between B2P and the C^3 region of IgG (28% homology). This 
homology is comparable to the homology among the IgG constant 
region domains. B2P also shows homology to about the same extent 
with the constant regions of IgM and IgE (19). 
In addition to these structural similarities, B2P resembles 
IgG in some of its functions. It can interact with the first 
component of the complement system like the Fc portion (%3 region) 
of IgG, and when aggregated, can activate complement (43). It is 
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similar to C^3 in its ability, when attached to sheep red blood 
cells, to form rosettes with guinea pig macrophages (43). Like 
C^3, $2^ can also bind to the Fc receptor of lymphocytes (46). 
There are some significant differences, however, between 
B2P and inmmoglobulin constant regions. While immunoglobulins 
are made only by plasma cells, 62^ is made by many nonlymphoid cell 
types as well as lymphocytes (40). The synthesis of &2y Is n°l 
linked to inmmoglobulin synthesis. Another important difference 
is that antisera to immunoglobulins will not react with B21-1 (8,15). 
Inspired by the associations between B2M and immunoglobulins, 
two major hypotheses have been proposed for the evolutionary origin 
of B2U• One is that B2V is a modern descendant of an immunoglobulin 
precursor gene, which later duplicates to code for the homologous 
constant regions of the immunoglobulin molecule (21,22,27,43,46). 
According to this theory, B2^ is equivalent to a free Cq3 domain. 
Evidence supporting this hypothesis includes the presence in 
invertebrates that lack immunoglobulins, of homologues of ^2^ > 
indicating that $2^jhylogenetically precedes immunoglobulins. This 
is also indicated by the presence of B2W on nonlymphoid cells. 
Homology with the constant regions of all classes of immunoglobulins 
is also evidence that 62^ occurred first, and immunoglobulins arose 
from its duplication. 
-3- 

The second major hypothesis about the origin of 62 u claims 
that the gene for arose after the duplication of the immuno¬ 
globulin precursor molecule, from a deletion of a segment in the 
IgG H chain precursor gene (58). The gene for 62^ would then include 
a short segment of the C^2 region and most of the C^3 region. This 
hypothesis is supported by the fact that both structurally and 
functionally, B2P most resembles the <3^3 region, yet it fails to 
explain why 69M would be as similar to IgM and IgE as it is to IgG. 
B2a is not likely to be the result of a proteolytic cleavage 
of a larger immunoglobulin for several reasons. There is no 
fraying at what would be the cleaved end. Also the amino acid 
sequence does not correspond exactly to a region of any known 
immunoglobulin. Antisera to the known classes of immunoglobulins 
do not react with 32^* 
Relationship with Major Histocompatibility Antigens. The 
serologically determined major histocompatibility antigens (in 
mice, the K and D region antigens) may be composed of four poly¬ 
peptide chains, two heavy chains linked by a disulfide bond and 
two light chains noncovalently bonded to the heavy chains (very 
similar to immunoglobulin structure). The noncovalent bonding 
is inferred from the ability to separate the heavy and light chains 
from each other by low pH without reduction and alkylation (45). 
This four chain model is not universally accepted, however, and 
may be due to a solubilization artifact. The alternate structure 
that has been proposed is a single heavy and light chain non¬ 
covalently bonded (01). An association between 621-1 and human histo¬ 
compatibility (HLA) antigens was first postulated when an 11,000 
MW fragment was isolated from human lymphoid cell culture medium 
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and found to have an identical amino acid composition to human 
Boy (37). Evidence for a structural association between HLA 
antigens and B2y has been shown by co-capping experiments (50,59, 
60). Capping is a manifestation of the mobility of membrane 
proteins. Antibodies to cell surface determinants cause redis¬ 
tribution of these determinants into patches on the cell membrane, 
followed by energy-dependent migration of these patches to form a 
cap at either pole of the cell. This aggregate may then be interna¬ 
lized for seme proteins, and the membrane protein is regenerated 
in three to eight hours (56). Treatment of lymphocytes with anti¬ 
serum against B2I leads to co-capping of HLA determinants and 32^, 
whereas treatment of the cells with antiserum against HLA antigens 
induces capping of HLA antigens and only some cell surface B2y* 
This occurs on other cell types in addition to lymphocytes (59). 
This experiment indicates that B2I-1 is associated with all serologically 
determined HLA antigens, but that the number of B2y molecules on the 
cell surface is in excess of the number of HLA antigens (by a six- 
to-one ratio, as later determined (41)). Therefore, some of the 
cell-surface is associated with HLA antigens, some with other 
cell surface antigens or receptors (7,41), and up to half of the 321 
is unassociated with other antigens (33). 
Another experiment which shows an association between B2u and 
HLA antigens involves the ability of antisera against S2u to precipitate 
HLA antigens as well as 321 (30). After lysis of radiolabelled 
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lymphocytes with a nonionic detergent, the cell lysates were sub¬ 
jected to iirmunoprecipitation with anti-^a* The precipitates were 
analyzed by sodium dodecyl sulfate - polyacrylamide gel electro¬ 
phoresis (SDS - PAGE), giving two peaks of radioactivity, corres¬ 
ponding to 45,000 MW and 11,000 MW (33). The 45,000 MW peak repre¬ 
sents the detergent-solubilized HLA antigen without 62a, while the 
11,000 MW peak is £31, showing that their association can be dis¬ 
rupted by denaturing conditions. 
Through further experiments it was discovered that not only is 
62a associated with HLA antigens, but 3ga is the small subunit or 
"comm portion fragment (cpf)" of HLA antigens (30,37,62). This 
was shown by both structural and functional identity of 62a and 
HLA-cpf. A direct structural comparison was done to determine anti¬ 
genic and physiochemical properties and amino acid sequence. Anti¬ 
genic identity was established using a double Ouchterlony technique 
(62), with antisera to 62a and HLA-cpf in two center wells, each 
encircled by wells containing 32a and wells containing HLA-cpf. 
Lines of identity were obtained throughout. Physiochemical identity 
was shown by the single band obtained with SDS - PAGE and disc 
electrophoresis of 32^ and HLA-cpf molecules, indicating identity 
of molecular size and ionic charge, respectively (62). Both 
molecules showed a major dense sharp band at an isoelectric point 
of 5.0 with isoelectric focusing (IEF), reinforcing the identity of 
ionic charge. The amino acid sequences were identical for the 
first 24 amino acids studied (62). 
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Another experiment showing that $2y is the small subunit 
of HLA antigens (45) used papain-solubilized I-HLA antigens 
125 
and After reduction and alkylation, fractionation on 
131 
Sepharose showed I activity at peaks corresponding to 33,000 
125 
MW and 12,000 MW, and I activity at 12,000 MW. The 12,000 
MW fraction containing t31j activity from the HLA molecule and 
125 
I activity from 321-1 was examined with two dimensional electro¬ 
phoresis and chromatography, and near identity was found. It was 
then demonstrated that reconstitution of the HLA molecule was 
possible with unlabelled 33,000 MW fragment and labelled 32^- When 
this was done, some of the label was seen associated with the 
33,000 MW protein, indicating that 32^ was a part of the recon¬ 
stituted HLA antigen. 
The 32^ subunit of all HLA antigens appears to be invariant, 
while the larger subunit is the region carrying the antigenic 
specificity (45). A question not yet answered is whether 32^ 
modulates the antigenic expression of HLA antigens in a manner 
similar to the effect of the light chain (L) on the heavy chain 
(H) of imnunoglobulins (51). 32^ may alter the availability of some 
HLA antigenic determinants (63), or may be required for the surface 
expression of HLA antigens (17). This is supported by the absence 
of HLA antigen expression on the surface of cells from the Daudi 
cell line, a human cell line that cannot make 3^ . 
Relationship with Mouse Thymus Leukeria (TL) Antigens. Thymus 
leukemia antigens are cell surface proteins found only on T lympho¬ 
cytes and lymphoma cells in mice and are coded for by a locus 
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adjacent to the major histocompatibility complex (H-2). They are 
very similar in structure to the mouse H-2 antigens. The snail 
invariant subunit has been found to be BpM (1,65), shown by 
migration identical to a Bg^ control on SDS - PAGE. The snail sub¬ 
units are bound noncovalently to two disulfide-linked heavy chains 
carrying the alloantigenic determinants. 
Relationship with Mouse Ss Protein. The Ss protein is a 
molecule coded for by the S locus of the H-2 complex, to date the 
only locus of the H-2 which controls a molecule not integrated into 
the cell surface (47). It has been found to be the murine equivalent 
of human complement component C4 (23). It also is composed of two 
subunits, one 23,000 MV and the other 12,000-14,000 MW. The 
smaller, which is devoid of carbohydrate and contains a single 
intrachain disulfide bond, may be 3^(14). If this is so, it implies 
important interrelationships among histocompatibility antigens, the 
complement system, and inrnunoglobulins. 
Relationship with Imnune Response-Associated (la) Antigens. 
Ia antigens are coded for by the I region of the mouse H-2 complex. 
They are found only on limited cell types, including lymphocytes 
(mainly B cells), spermatozoa, macrophages, and epidermal cells (13). 
The mixed lymphocyte reaction (MLR) detects differences in I region 
products, so Ia antigens are described as being "lymphocyte- 
determined". In the MLR it is mainly B cells which stimulate a 
response and T cells which respond to allogeneic Ia antigens on the B 
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cell surface by proliferation. It was found that when the 
responder T cells were treated first with antisera to ^ > their 
proliferative MLR response was inhibited (35). The antibodies may 
interfere with recognition of the allogeneic la antigen by the T 
cell. This could indicate that they may be bound to an la receptor 
of T cells, which thus may contain but this has not teen shown 
conclusively. If the stimulator B cells are treated first with 
anti-B2U, T cells in the MLR still respond with normal proliferation 
whereas B cell treatment with antisera to la antigens leads to 
inhibition of the T cell proliferative response (47). This seams 
to indicate that ^ is not a subunit of the la antigen, since anti¬ 
sera to did not appear to block the la antigen. Cell surface 
la antigens solubilized from murine lymphocytes do not seen to be 
associated with 821-b yet la antigens secreted by lymphocytes and 
obtained without chemical extraction do show an association with 62^ 
(3,13). Ia antigens can be identified in serum, associated with 
high density lipoproteins (HDL) as well as possibly with B2U (12,13) 
It is not yet known if this difference between secreted and cell- 
bound Ia antigens is real or merely an artifact or a consequence 
of isolation technique. 
Relationship with Allogeneic Effect Factor (AEF). AEF is a 
soluble irunune mediator made by alloantigen-activated T cells 
which regulates triggering and differentiation of B cells in vitro 
(2,3)o It is not antigen-specific. Like immunoglobulins and 
histocompatibility antigens, it is made up of two kinds of subunits. 
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The 40,000 MW subunit contains la antigenic determinants, while 
the 12,000 MW fragment appears identical to Bov(3). AEF can be 
completely and specifically absorbed by anti-BgiJ (3). AEF is the 
first molecule with I region determinants discovered to contain 
B2U as part of its structure. This association may indicate that 
32P plays a role in cell-cell interactions. 
Relationship with the T Cell Receptor. While the B cell 
receptor for antigen has been found to be cell surface immunoglobulin, 
the nature of the T cell receptor has remained a mystery. It has 
been postulated that > with its similarity to immunoglobulin 
structure and its linkage with histocompatibility antigens, may be 
a subunit of the T cell receptor (4,60). To investigate this, the 
effect of anti-^y on responder and effector functions of T cells 
was observed. Anti-B2W inhibited the proliferative response of T 
cells to mitogens (e.g. PHA), to antigens to which the T cells were 
sensitized (e.g. PPD), and to alloantigens in the MLR. This inhibi¬ 
tion could be prevented by addition of pure B2^ which bound to the 
anti-32y , preventing its action on T cells. The effector function 
of T cells is also inhibited by anti-32y , as shown by the ability 
of anti-Bgy to block cell-mediated lympholysis (CML). This can be 
prevented by the addition of purified 82^ » to which the anti-32V 
will preferentially bind (4). These findings favor the involvement 
of 3£W in the T cell receptor. However the invariance or lack of 
polymorphism of 32^ argues against its role as a T cell receptor 
subunit, because it would appear to be incapable of mediating 
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differential receptor activity (4). Also the effects of anti-BoiJ 
on T cell responder and effector functions may be explained without 
invoking a necessary link between Bgy and the T cell receptor. A 
disturbance of the cell membrane by anti-32V-1 rnay cause the inhibition 
of T cell response to stimuli. So the question of whether Bgy is a 
part of the T cell receptor remains unsettled. 
Studies of B21-1 in many different species give information about 
the degree of genetic polymorphism or conservation of structure of 
32U that exists among species. This is important in order to gain 
insight into the structural, functional, and evolutionary relation¬ 
ships that exist among 32^ inmunoglobulins, histocompatibility antigens, 
and other cell surface molecules. 
While most work done in the past in transplantation biology 
has utilized the mouse and its well-defined 11-2 complex, there are 
disadvantages to the use of such a small animal. Many animals are 
required to obtain a quantity of antigen sufficient for biochemical 
characterization. Also the mouse is not an adequate model for the 
transplantation of some organs and tissues. It was for these reasons 
that a large animal model suitable for transplantation studies was 
sought. Miniature swine were chosen for their size and favorable 
breeding characteristics (54). They reach sexual maturity at four 
to six months of age, have an estrous cycle of three weeks, and have 
a gestation period of about four months. Homozygosity of the major 




Analysis of the swine major histocompatibility antigens by 
SDS electrophoresis has shown a 42,000 MW peak (miniature swine 
leukocyte antigens or MSLA, comparable to the HLA and the mouse H-2) 
and an 11,000 MW peak (the putative miniature swine62w) (36)- The 
isolation of this miniature swine B2u, which is the main topic of 
this paper, was undertaken in order to study different inmunological 
parameters in the pig. Since this animal is a good transplantation 
model, it was desirable to learn more about the antigens making up 
its major histocompatibility complex. B2u has previously been isolated 
and purified from several different species. 
Human was the first to ^ isolated. It was obtained from 
the urine of patients with impaired renal tubular function as a 
result of Wilson's disease or chronic cadmium poisoning (8). The 
isolation procedure had four main steps: 1) ultrafiltration using 
dialysis tubing to concentrate the urine; 2) preparative zone 
electrophoresis in a Pevikon block, first in barbital buffer and then 
after concentration ctf the $2^ Peak> in borate buffer (this separates 
the urinary proteins according to their charge); 3) gel filtration 
or gel chromatography with a Sephadex G-100 column to separate 
molecules according to their molecular weight; 4) ion exchange 
chromatography, first with DEAE-cellulose and then with sulfoethyl 
Sephadex. Column eluates were analyzed through all these steps by 
the Folin method to determine total protein, and by Ouchterlony 
technique or radial imnunodiffusion (RID) to determine Br>y levels* 
Confirmation of the purity of the isolated B2y obtained by four 
procedures: 1) Ouchterlony imnunodiffusion, which showed that B2p 
present in plasma and urine gave a line of identity with purified 
g2y ; 2) starch gel electrophoresis, which resulted in one zone 
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free of contaminants; 3) irmiunoelectrophoresis (IEP), which 
showed only one band; and 4) equilibrium ultracentrifugation, which 
showed a molecular weight of 11,600 for the purified 62^ molecule. 
A simplified method of isolating 32U from urine involved the 
use of affinity chromatography with anti-BgU iirmunoadsorbent columns 
to bind $2y and HLA antigens, separating them from other urinary 
proteins (42). Another method also using urine as a source of B2M > 
proposed the use of an irrmunoadsorbent column prepared with anti¬ 
serum to normal human serum and enriched with monospecific antiserum 
to glycoproteins (11). There would be very few antibodies to 32^ and 
HLA antigens on the column since the concentration of these antigens is 
quite low in normal sera, so that the high amounts of &n\i and HLA 
antigens in the urine of renal patients would pass right through 
this column. The other proteins also found in the urine of these 
patients are proteins found normally in sera, and so these would be 
bound to the column. 
A three step procedure using ultrafiltration, gel filtration, 
and isoelectric focusing (IEF) was also shown to be effective in 
isolating human 32^ from urine (64). A flat bed IEF method in poly¬ 
acrylamide gel showed high preparative capability. This isolation 
method utilized radioimmunoassay (RIA) to follow the yield of $2^ 
after each step. 
32^ has also been isolated from guinea pig urine (16), following 
treatment of the animal with sodium chromate, an agent which leads to 
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renal tubular damage (5). Two forms of B2y were discovered. They 
were irnmmologically identical (shown by Ouchterlony lines of 
identity), but differed in amino acid composition (the minor form 
had one fewer lysine residue) and isoelectric point. Both forms 
cross-reacted with human and rabbit B2y * Siving lines of partial 
identity in Ouchterlony immunodiffusion. Variants of ^ Prove 
to be particularly helpful in determining its biological activity and 
evolutionary origin. Guinea pig was isolated by a procedure in¬ 
volving ultrafiltraion, gel filtration with Sephadex G-100, ion 
exchange chromatography using DEAE cellulose, zone electrophoresis 
in borate buffer, and a second gel filtration (16). Total protein and 
B2M activity were identified by absorbance at 280 nm and single radial 
immunodiffusion, respectively. Purity of the isolated guinea pig 
g2n was confirmed by several methods, including agarose gel electro¬ 
phoresis, SDS - PAGE, amino acid analysis, IEF, and Ouchterlony 
irnmunodif fusion. 
Urine from rabbits poisoned with sodium chromate has been another 
source from which B2u has been isolated (6,20,21). The isolation pro¬ 
cedure was similar to that used for human and guinea pig 62^: ultra¬ 
filtration, gel chromatography, zone electrophoresis, and DEAE 
cellulose chromatography. The isolated rabbit $ \i shows a great 
similarity with human B2u in molecular weight and size, amino acid 
composition, presence of an intrachain disulfide loop, and electro¬ 
phoretic mobility. Rabbit ($2^ has also shown homology with rabbit 
IgG, particularly with the C^3 region (20). By examining amino acid 
sequences of £>2^ molecules from humans, rabbits, and dogs, it can be 
seen that B2U structure is highly conserved in evolution, and that 
B^and CU2 regions of immunoglobulins show more conservation of 
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structure across species than the C^l and Cq3 regions (21) . 
The mouse homologue of human $2^ has been isolated (2,39, 
53) and has been shown to form the snail subunit of H-2 antigens 
coded for by K and D regions (serologically determined), just as 
human B9y has been found to be a part of HLA antigens. Its homology 
to human 62M has been found to be a part of HLA antigens. Its 
homology to human is demonstrated by its ability when on the 
cell surface, to bind to anti-human 62^, which in the presence of 
complement, leads to lysis of the cell (53). It also shows amino 
acid composition similarity to human $2^, including presence of an 
intrachain disulfide bond, and antigenic similarity (39). The 
amino acid sequence shows much homology with human, dog, and rabbit 
62^ as well as with mouse IgG, particularly the C^3 region (2). The 
isolation procedure used for mouse BgtJ involved gel filtration, ion 
exchange chromatography, and column electrophoresis (39). 
$2^ has been isolated from the urine of dogs with kidney 
damage induced by surgery and X-rays (52,57). A typical procedure 
of ultrafiltration, gel filtration, starch gel electrophoresis, and 
DEAE cellulose chromatography was used. The amino acid sequence of 
the dog homologue is similar to that of human B2I-1, but antisera to 
the human B a will not precipitate dog B0p. 
2 z 
Lactollin is a molecule that had been previously isolated 
and characterized, but was recognized only recently to be the cow 
hcmologue of human B0m (31). Its amino acid sequence is similar 
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to that of the niolecules of other species. Unlike other 
species, however, it is not found in a monomeric form, but is 
made up of four noncovalently linked subunits, each of about 
12,000 MW. 
Thus, in all the different species, the general isolation 
procedure for 62^ involved a combination of ultrafiltration, gel 
filtration, ion exchange chromatography, and zone electrophoresis. 
The purity of the isolated $2^ 'ms confirmed by Ouchterlony immuno¬ 
diffusion, starch gel electrophoresis, or amino acid analysis. 
Based on this information, a procedure for the isolation of 
miniature swine 62^1 from serum was devised. 
-16- 

Isolation of 3from miniature swine serum. 
—-zr———' 
MATERIALS AND METHODS 
Animals„ A miniature swine from the inbred herd maintained 
at the National Institutes of Health Animal Center, Poolesville, 
Maryland, was poisoned with 20 mg/kg sodium chromate injected sub¬ 
cutaneously, as previously described (5). In rabbits, the maximum 
induced proteinuria occurs three to five days post-injection (20), so 
urine (via a catheter) and a large sample of blood were collected from 
the pig daily, from day three until day seven, when the pig was exsanguinated. 
Sodium azide was added to the urine samples which were then kept frozen 
at -20°C. The blood samples were centrifuged and the sera were also 
stored at -20°C. 
Radioinminoassay (RIA). In order to isolate miniature swine 62^ 
it was necessary to have an assay capable of detecting 32V1 activity in 
column fractions from each step of the isolation procedure. It had 
been shown that a heterologous radioimmunoassay can be used to detect 
homologues of ^ in sera from various vertebrate species (28). There 
is sufficient homology among the (3 2 a molecules of different species 
for the B2a of one species to bind to the antisera against the of 
another species. In the system described (28), significant binding 
125 
(about 60%) occurred between I-human f^a an<^ goat-anti-rabbit 
(GAR) B2y • This binding could be inhibited by unlabelled B2y 
molecules from many species, including the pig, which showed 81% 

inhibition (28). A homologous system using binding between 
labelled BQy and antisera to 32y from the same species, was not 
inhibited by B2y from another species, so this could not be used. 
The heterologous radioimmunoassay using inhibition of binding 
between 125I-human 32y and GAR 32y was used in this isolation pro¬ 
cedure. The GAR B2y was obtained from Doctor Thomas Kindt 
(National Institute of Allergy and Infectious Disease, National 
Institutes of Health), and the IgG fraction of it was coupled to 
Sepharose for use in the assay by Doctor Stuart Rudikoff (Laboratory 
of Cell Biology, National Cancer Institute, National Institutes of 
Health). Purified human 32u was kindly provided by Doctor Howard 
Grey (National Jewish Hospital Research Center, Denver, Colorado). 
125 
It was labelled with I by the lactoperoxidase-Sepharose gel 
iodination method as previously described (24). 
An RlA binding assay was set up in duplicate using a constant 
amount of 125I-human B2y and several different quantities of Sepha- 
125 
rose-bound GAR 32y. Before use, the I-human B2u was diluted so 
that each 100 yl contained about 20 ng of protein (as estimated by 
125 
absorbance at 280 nm) and 50,000 counts of I. The other components 
of this solution were: 1) emulphogene, an emulsifier added in a ratio 
of about 25 to 30 yl per ml of solution; 2)phosphate-buffered saline 
(PBS), pH 7, with 0.01% NaN^ and 1% bovine serum albumin (BSA); 3) 
57Cobalt, about 500,000 counts per ml of solution. This was added as 
125 
a volume control to allow calculation of the bound I-human 3 2^ 
125 
without having to wash all the free I-human 32y from the precipitate (29). 
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Binding and inhibition assays were both set up in Brinkmann 
microfuge tubes, each brought to a final volume of 300 ul. In 
both of these assays a background tube containing only the PBS-BSA 
125 
buffer and an antigen control tube containing only I-human B2y 
and the buffer were set up. A control for nonspecific antibody 
binding was also made, using 125I-human f^y and another Sepharose- 
bound antibody. All tubes were mixed continuously overnight at 
4°C to optimize binding. Then after centrifuging for one minute 
in a Brinkmann microfuge, about fifty percent of the supernatent 
of each tube except the antigen control was removed. The antigen 
125 
control tube was counted in its entirety, to give the maximum 
counts possible. Samples were counted in a gamma counter capable 
of counting two channels, ^^i and ^Co, for each tube. 
For the inhibition RIA assay, an amount of GAR 32y was chosen 
that resulted in fifty percent binding. In addition to the controls 
used for the binding assay, a zero-inhibition or 100% binding control 
125 
was set up, containing only the I-human B2y and Sepharose-bound 
GAR B2y. A11 experimental samples contained these same quantities 
of 125I-human 32u and GAR 32y plus an inhibitor which could be 
serum, urine, eluate from a column, or anything containing B2u. Un¬ 
labelled human B2y was used as a standard inhibitor in several 
different dilutions each time the assay was run. Samples with a 
high percent inhibition were diluted in the PBS-BSA buffer and 
titered to find the maximum dilution that would still show inhibition. 
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The percent binding was calculated by the formula: 
<?£ = 100 
Ea -eA 
XTa - e) 
where E = 125I channel of the experimental 
125 
tube, e = 57Co channel of the experimental tube, A = I channel 
of the antigen control, and a = 57Co channel of antigen control (29). 
Additional corrections were made for background counts. The percent 
inhibition was calculated by the formula. 
of zero inhibition control - 7cB of sample inhibitor 
------TriT^ 7»rvrvl‘T%nl 
%I = °1<E> of zero inhibition control" 
where is percent binding calculated as above (32). 
Gel Chromatography. 100 ml aliquots of serum from the 
poisoned pig were centrifuged at 15,000 rpm for 15 minutes to remove 
any clumps and then chromatographed on a Sephadex G-75 column 
(200 x 5 cm) in borate buffer (0.2 M boric acid, 0.16 M NaCl, pH 8.0). 
At a flow rate of 25 ml per hour, each 100 ml sample took about six 
to seven days to be eluted from the column. About 270 18 ml 
fractions were collected. Absorbance at 280 nm ms used as an 
indication of total protein. Fractions showing B2w activity as 
assayed by their ability to inhibit l2°I-human -GAR binding 
in the RIA, were pooled. Pools were concentrated by ultraflltration 
in an Amicon concentrator with a UM-2 filter, retaining proteins with 
a molecular weight greater than 2000 Daltons. The pass-through was 
assayed for B2u activity, to be sure that 62a was not being lost 
through the filter. Initially a UM-10 filter had been used, but there 
was too great a loss of B2u activity with this pore size. 
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Isoelectric focusing (IEF). 1.0 ml of the UM-2 concentrate 
was dialyzed overnight into glycine-HCl buffer to decrease the salt 
concentration, using Spectropor 3 tubing, which retains molecules 
greater than 3500 MW. This sample was then loaded on a 110 ml 
preparative IEF column run at 4°C for 24 hours. Carrier ampholyte 
solutions of pH range from 3 to 10 were used. A solution of 50% 
sucrose was used to form a density gradient to stabilize the protein 
zones. 45 fractions of two mis each were analyzed for pH, for total 
protein by absorbance at 280 nm, and forSgy activity by RIA. 
Ion Exchange Chromatography. Another aliquot of the UM-2 
concentrate of serum $2^ was dialyzed overnight into 0.01 M Tris, 
pH 8.6, and chromatographed on a 9 ml DEAE column equilibrated in 
the same buffer. A gradient elution device was connected to the 
column, with a 60 ml mixing chamber containing the equilibration 
buffer, and a 60 ml reservoir of equilibration buffer containing 
0.2 M NaCl. After the first 10 tubes of about 2 ml each were 
collected, elution with the linear salt gradient was started. About 
50 more tubes were collected and all were assayed for activity by 
RIA. Those with activity were pooled and then concentrated by 
ultrafiltration using the Amicon with a UM-2 filter. This concentrate 
was then equilibrated with sodium acetate 0.01 M, pH 5.6, by dialysis 
overnight using Spectropor 3 (3500) tubing, and was placed on a CM 
cellulose column equilibrated in the same buffer. It was eluted with 
a linear salt gradient made by mixing the 0.01M sodium acetate buffer 




Radioinmunoassay. I-labelling of the human B2P to be us©d 
in the RIA resulted in a specific activity of 3010 cpm/ng. The RIA 
125 
binding assay using the ~ I-human B2P and GAR B2P antiserum showed 
binding that plateaued at about 80 percent (Figure 1). Based on this 
binding curve, the RIA inhibition assay was set up using the ratio of 
125 
GAR $2^ to I-human B2P that gave 50 percent binding, as determined 
from the binding curve. Different concentrations of unlabelled 
human Bp were used as standard inhibitors of binding, and Figure 2 
shows the inhibition curve obtained. A plateau of inhibition 
occurred at about 65 percent. Fran the percent inhibition observed 
in sera and urines, an estimate of their B2P concentration could be 
made using this standard curve. This assumes that unlabelled human 
125 
B2P and pig 62^ bind to I-human B2P to the same degree. In the 
past (28), human and pig sera have both shown about 80 percent 
125 
inhibition of the GAR B2P - I-human heterologous system, so 
this assumption is probably valid. By this estimation the concentra¬ 
tion of B2P in normal pig serum was 1.46 ug/ml. The serum from a 
pig poisoned with sodium chromate contained about 14.64 ug/ml, about 
a tenfold increase over the normal pig serum. 
With this RIA inhibition assay established as a reliable method 
of detecting and estimating the quantity of B2P activity, it was then 
used to determine fractions with B2^ activity in each step of the 
isolation procedure. The isolation described here was only done with the 




Gel Chromatography on Sephadex G-75. Serum from the pig 
poisoned with sodium chromate was chromatographed to separate out 
small molecular weight molecules like B2y (a1:)OUl: 12,000 Daltons) from 
the larger serum proteins. Figure 3 shows this separation, with the 
major peak in OD280, presumably the major serum proteins, eluted 
from the column first, followed by and not overlapping with the peak 
having the greatest B2I-1 activity. The first peak of 32u activity 
may represent a snail amount of 32y that is still bound to histo¬ 
compatibility antigens, thus eluted with the higher molecular weight 
proteins. The fractions after the major B2y peak that show B2y 
activity may contain smaller molecular weight breakdown products of 
B2y with less RIA inhibitory activity. Two subsequent serum separa¬ 
tions on this Sephadex G-75 column showed that absorbance at 280 nm 
and 32y activity occurred in approximately the same fractions as in 
the first separation. 
Isoelectric Focusing. After pooling the fractions with the 
greatest B21J activity, as shown in Figure 3, a portion of the con¬ 
centrated pool was analyzed by isoelectric focusing in an attempt 
to separate B2y from molecules of the same size but of a different 
charge or isoelectric point. Although the pH gradient was good, the 
B2y activity did not focus in one fraction, but was scattered over 
a wide pH range (Figure 4). To determine whether the RIA might be 
showing nonspecific inhibition by sucrose or by sane other molecule 
used in the procedure, the fractions were dialyzed. This resulted 
in B2y activity that was somewhat more focused, but still quite 
diffuse. Therefore this IEF procedure was abandoned, rather than 
using up more sample to repeat it. 
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Ion Exchange Chromatography. It was decided instead to 
separate the Sephadex G-75 concentrated pool by charge with a DEAE- 
cellulose column. The majority of the did not pass straight 
through the positively charged DEAE column (pH 8.6) but rather, showed 
binding to the column, indicating the negative charge of pig B2u at 
this pH. It was eluted only after the salt gradient was started 
through the column, tost of the B2u activity appeared in one distinct 
peak, pooled as shown in Figure 5. This pool was then concentrated 
and applied to a CM cellulose column (pH 5.6). This step was not 
successful. Fractions eluted from the column showed little 
activity, probably due to aggregation and failure to be eluted at the 
acid pH. 
A sumnary of results from the successful isolation steps was 
conpiled in Table I. The total amount of B2p resulting from each 
purification step (as determined by RIA inhibition) was compared to 
the total amount of B2p in the original serum sample to obtain a 
percent yield for each step. Also the ratio of total 32p to total 
protein as calculated by absorbance at 280 nm, in the original 
serum was compared to this ratio in each subsequent purification step, 
to determine how manyfold a purification was achieved. The net 
result of the isolation procedure up to and including the DEAE- 
cellulose ion exchange step was a 52.2% yield of 32p with respect 
to the amount of B2p activity in the original serum, and a greater 






Volume of GAR * (fiL.) 
. Radioimmunoassay binding curve. Concentration of GAR 
125 
32^ giving 50 percent binding is shown. (20 ng. of I- 






Amount of human P2P (nff) 
Radioimmunoassay inhibition curve. Standard unlabelled 
human gg3 was used as inhibitor of a heterologous system 
125 
of 20 ng I-human 62^ and 75 yl goat anti-rabbit (GAR) 
$2^ per microfuge tube. 

Percent 0^2/30 
Elution tube number 
Figure 3. Sephadex G-75 gel filtration of pig serum. A 200 x 5 cm 
column was run in 0.2n borate buffer, pH 8.0. 0DOgQ (---■») 
was used as a measure of total protein, and percent inhibition 
1 nrz 
of heterologous (I-human $2^ -GAR 32g) RIA binding (-) 
was used as an index of 32^ activity. Fractions with 













10 20 30 40 
Elution tube number 
Figure 4. Isoelectric focusing. The concentrated peak from the 
Sephadex G-75 column was applied to a 110 ml preparative IEF 
column. A gradient from pH3 to pHIO (••»■'*) was formed, stabilized 
by a 50% sucrose gradient. The 0D2gQ(*-•) of the fractions is 
shown on the upper part of the graph. On the lower part, the 
$2^ activity (as determined by percent inhibition of a hetero¬ 
logous RIA inhibition systeri) is shown for the undialyzed (■—«) 






t Piution t-ube number 
Figure 5. Ion exchange chromatography using DEAE cellulose. Elution 
diagram of the concentrated $ y peak (from the Sephadex G-75 
column) applied to a DEAE cellulose column (0.01 M Tris, 
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The isolation of miniature swine was undertaken in order 
to further investigate the structures of $2^ and the histocompati¬ 
bility antigens and their horology with the comparable molecules in 
other species. A remarkable retention of structural homology in the 
32^ molecule has been shown in the many species studied thus far. This 
is reflected in iirmunologic cross-reactions that have been detected 
between mouse and rabbit and between mouse and human 62^ by RIA 
assays (38), and between rabbit and human $2^ by Ouchterlony analysis 
(6). This cross-reactivity was utilized in the present study, where 
miniature swine B2M showed inhibition of a heterologous RIA system of 
goat-anti-human anc* human 62^- This inhibition assay provided 
a means of following the progress of the miniature swine B2U isolation. 
Whereas most other studies have used urine of poisoned animals 
or of humans with kidney damage as a source of ^2^ > this study was 
done using serum of a poisoned pig, which also showed high levels of 
32y activity. (The urine will be used in the same manner, to get 
the maximal amount of available from each animal and provide more 
B2y for chemical characterization). Isolation steps were basically 
similar to those used in purification of human, guinea pig, rabbit, 
and mouse 32y. Most of these used ultrafiltration, gel chromatography, 
and some form of ion exchange chromatography. Isoelectric focusing 
had only been used in one of the human 32M isolation procedures (64), 
but did not result in the same success in the present isolation schene 
with the pig sera. The failure of the B2U to focus may have been due 
to nonspecific binding of B2P to proteins of different isoelectric points. 
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Various attempts to further purify the pig 3oP by CM cellulose or gel 
filtration at acidic pH have been unsuccessful, possibly due to in¬ 
solubility of the pig 30y at this pH. Instead, following the DEAE- 
cellulose step, an additional gel chromatography step using Biogel- 
P10 at a basic pH is currently being carried out. Preliminary SDS gel 
electrophoresis tests on the concentrated DEAE pool using a method 
previously described (18,34) show a 11,500 MW peak free of most 
contaminants. This material is now being assayed for purity by amino 
acid sequencing. When sequenced, it can be compared with the &2V 
molecules of other species to determine the degree of homology. 
Another use for the purified 32^ is in reassociation studies with 
purified MSLA antigens, to see if full alloantigenic activity can be 
recovered. 
Studies are being carried out now using the miniature swine $2^ 
isolated as described above to make an antiserum to swine $2^• A 
goat was injected intramuscularly at four sites with a total dose of 
100-200 ug of purified swine 32t (from the concentrated DEAE pool) in 
complete Freund's adjuvant and was boosted in the same manner at three 
weeks. Sera from weekly bleeds of the goat show precipitin bands with 
the purified swine i-n Ouchterlony irrmunodiffusion and were cytotoxic 
to pig lymphocytes. Preliminary SDS polyacrylamide gels with radio- 
labelled miniature swine lymphocyte antigens indicate that the goat- 




Further experiments will attempt to use the antiserum to swine 
e2u to make an anti-32y inmunoadsorbent column for use m the isolation 
of MSLA antigens. There have been problems in the past with the use 
of anti-BQy inmunoadsorbent columns as a means of isolating HLA 
antigens, based on difficulty in elution of the antigens from the 
anti-32^• The noncovalent binding between B2y and the histocompati¬ 
bility antigens was readily disrupted in solution, but more stringent 
conditions were required to elute the antigen from the anti-32y column. 
This may have been due to aggregation of HLA molecules, forming a 
network on the column which was difficult to elute. With 0.1% SDS at 
pH 7, however, 40-50% of the HLA antigenic activity put on the column 
was able to be eluted (25). Others have shown effective elution of 
HLA antigen from an anti-B2y inmunoadsorbent column with excess B2y 
or with 0.05 M glycine/HCl buffer (pH 2.4). These methods gave 60 to 
90 percent recovery of alloantigenic activity (54). Anti-32y inmuno¬ 
adsorbent columns may avoid the need for a whole series of fractionations 
and may yield a product of higher purity than rnultistep procedures, 
based on the specific binding of the 32y moiety of the MSLA antigens 
to the anti-62y on the column. Anti-B2y can also be used in inrnuno- 
precipitation gels, to attempt to precipitate out B2y 3-nd MSLA antigens 
and any other cell surface molecules with which B2y may be associated. 
When isolation and purification of the MSLA antigens is achieved, 
these antigens can be sequenced and compared with irnrunoglobulin 
structures and with H-2 and HLA antigens to establish homology. Further 
studies will look at homology within the three different homozygous 
MHC types, AA, CC, and DD, that have been established in miniature 
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swine (55). Then the homology of AA, (X, and DD antigens with 
histocompatibility antigens of the A, B, and C HLA regions can be 
investigated. In the sequencing of MSLA antigens, peptides are 
formed and can be studied to see if they retain the alloantigenic 
activity of the intact antigen. Another use for purified MSLA 
antigens is to insert than in liposomes or phospholipid model 
membrane systems, to see if they maintain their activity and are 
able to stimulate mixed lymphocyte culture (MLC) and cell-mediated 
lympholysis (CML) reactions. 
Therefore, the isolation of miniature swine B2y not only 
provides a purified 32y molecule for study and comparison with other 
species, but also facilitates the purification of MSLA antigens. 
There are multiple uses for these purified MSLA antigens, all leading 
to a better understanding of the MHC and its role in transplantation 
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